72 results about "Respiratory pathogen" patented technology

The invention discloses a nucleic acid combination product, a kit and a method for detecting various respiratory tract pathogenic bacteria. The nucleic acid combination product comprises a primer pair and a probe, wherein the sequences of the primer pair and the probe are respectively shown as SEQ ID NO: 1-SEQ ID NO: 24. The nucleic acid combination product realizes synchronous detection of various pathogens through a one-tube eight-color fluorescent PCR, freeze-drying and ultrasonic direct diffusion method technology, significantly reduces experimental operation steps, shortens detection time, reduces the complexity of result interpretation, and has strong anti-interference capability and high sensitivity.

The invention designs a carbapenem drug-resistant gene nucleic acid fluorescent PCR method detection kit and application thereof, the kit uses Taqman fluorescent probe multiple amplification technology to detect carbapenem drug-resistant genes, the kit comprises a nucleic acid reaction liquid Mix1 and a nucleic acid reaction liquid Mix2, the nucleic acid reaction liquid Mix1 is used for detecting drug-resistant genes IMP, NDM and OXA48, the nucleic acid reaction liquid Mix2 is used for detecting drug-resistant genes IMP, NDM and OXA48, and the nucleic acid reaction liquid Mix2 is used for detecting drug-resistant genes IMP, NDM and OXA48. The nucleic acid reaction liquid Mix2 is used for detecting drug resistance genes VIM, KPC and OXA23. The method is high in detection specificity, and the detection result is visual and easy to interpret. Clinical doctors are assisted to judge respiratory tract pathogen infection more comprehensively and more accurately. The kit covers six carbapenem drug resistance genes, is more comprehensive and accurate in detection, and is high in specificity and sensitivity. Meanwhile, multiple sample types can be detected, a sputum sample, an excrement sample and a rectum swab sample are detected through paramagnetic particle extraction, and pure bacterial colonies are directly detected without extraction.

The invention discloses a nucleic acid combination product for detecting various respiratory pathogens, a kit containing the nucleic acid combination product and a method. The nucleic acid combination product comprises a primer pair and a probe, wherein the nucleotide sequences of the primer pair and the probe are respectively shown as SEQ ID NO: 1-21. According to the nucleic acid combination product, on the technical basis of Taqman fluorescent quantification, seven targets can be detected by one tube, so that the time and energy of operators are greatly shortened, and the nucleic acid combination product is convenient and rapid, is not easy to make mistakes, and is simpler and easier to understand in result interpretation.

The invention relates to the technical field of biology, in particular to a primer probe combination product for respiratory tract infection detection. A plurality of specific primers and self-quenching probes are integrated in a single reaction system; simultaneous, rapid and rapid detection on 15 respiratory pathogens (including influenza A virus, influenza B virus, respiratory syncytial virus, severe acute respiratory syndrome coronavirus 2, mycoplasma pneumoniae, parainfluenza virus, rhinovirus, enterovirus, coronavirus, adenovirus, metapneumovirus, bordetella pertussis, bocavirus, chlamydia pneumoniae and chlamydia psittaci) is realized. The detection is accurate.

The application discloses a set of molecular targets, primer compositions, methods and applications for identifying respiratory pathogens, the respiratory pathogens are novel coronavirus, influenza A virus and respiratory syncytial virus, and nucleotide sequences of the molecular targets are shown as SEQ ID NO:1-3. The application provides molecular targets, primers and probes for detecting three respiratory pathogens, and establishes a triple real-time RT-RAA detection technology, which can realize rapid identification and differentiation of three respiratory infectious disease pathogens with similar clinical symptoms within 30 minutes, reduces the operation threshold of the existing detection technology, realizes the target of rapidly, simply and accurately identifying and differentiating the three viruses, meets the needs of early clinical diagnosis of infection, provides technical support for precise medication, and has wide application value.

The application discloses a nucleic acid combination product, a kit and a method for detecting multiple respiratory tract pathogenic bacteria. The nucleic acid combination product comprises a primer pair and a probe, wherein the sequences of the primer pair are respectively shown as SEQ ID NO:1-SEQ ID NO:24. The nucleic acid combination product realizes the synchronous detection of multiple pathogenic bacteria through one-tube eight-color fluorescence PCR, freeze-drying and ultrasonic direct extension technology, significantly reduces the experimental operation steps, shortens the detection time, reduces the complexity of result interpretation, and has strong anti-interference ability and high sensitivity.

The invention relates to the technical field of molecular biological detection, in particular to a multiplex digital PCR (polymerase chain reaction) kit for detecting various respiratory pathogens, which comprises a primer pair aiming at various targets and a unique fluorescence proportion coding probe group, each group of probes comprises probes marked with two fluorophores with different proportions, and high-throughput identification of multiple targets in a single reaction is realized through fluorescence proportion combination. The kit is designed by adopting a gradient reaction system, primer pairs are grouped according to a non-interference principle, and concentration is adjusted according to target expected abundance differentiation, so that amplification bias is effectively inhibited, and quantitative accuracy in a wide dynamic range is ensured. The invention also provides a complete detection scheme containing the internal standard system, and is suitable for rapid, accurate and multiple absolute quantitative detection of respiratory tract infection pathogens.

The application discloses a swab collecting and transporting device for respiratory pathogen detection and relates to the technical field of medical devices.The device comprises a tube body and a tube cover, and the tube body is composed of an outer tube body, an inner container and a vacuum heat preservation layer; the inner container is provided with a U-shaped breaking gap at the container mouth, the gap is provided with a wedge-shaped cutting edge, and a limiting block provided with anti-skid serrations is arranged below; the container mouth is provided with a sealing flow blocking block and a rubber plug body, the plug body is provided with a medical hydrophilic liquid absorbing composite buffer layer at the bottom; and the outer tube body is provided with a real-time temperature display unit, which can adopt reversible heat-sensitive color-changing strips or waterproof miniature digital display modules.The wedge-shaped cutting edge and the limiting structure are used to realize accurate and labor-saving breaking of the swab, so that sample spatter and pollution are avoided; multi-stage sealing and liquid absorbing buffer layer double anti-overflowing can quickly absorb and inactivate leaked samples; vacuum heat preservation is combined with real-time temperature monitoring to guarantee the cold chain storage environment of the samples.The whole operation is convenient and safe, the device is suitable for clinical sampling processes, and the reliability of respiratory pathogen sample collection, preservation and transportation can be effectively improved.

The invention relates to the field of biological medicines, and discloses application of a GOSR1 gene in prevention and / or treatment of respiratory pathogens. The GOSR1 gene is specifically knocked down, so that the gene and protein expression level of the pathogen can be reduced, and the proliferation of the respiratory pathogen can be remarkably inhibited. In addition, the invention also discloses that overexpression of the GOSR1 gene can activate proliferation of pathogens in cells infected by respiratory pathogens. Based on the regulation effect of the GOSR1 gene on respiratory tract pathogen proliferation, a brand new strategy is provided for treatment of respiratory tract pathogen infection, and the application is particularly suitable for intervention of influenza A virus infection.

The application provides a quality control for detecting respiratory pathogen nucleic acid, which comprises any one or more of the following respiratory pathogens: coronavirus, influenza virus, adenovirus, Mycoplasma pneumoniae, Streptococcus pneumoniae, rhinovirus or / and Legionella pneumophila. The full-length genome sequence of the coronavirus is divided into 6 target fragments, each with a length of 4000-5500 bp. The quality control of the application covers all detection target sequences (or target points) of the coronavirus, has a wide coverage, comprehensively detects target points, and does not have the phenomenon of missed detection. The quality control of the application contains main respiratory pathogen infections, has a wide range, and uses real virus samples and lentivirus samples as raw materials, and has more accurate detection target points. The preparation of the coronavirus quality control of the application integrates the target gene sequence into the host genome through the lentivirus vector, knocks out the self-replication gene in the preparation process, and has a "self-inactivation" ability, so that the recombinant lentivirus cannot replicate in the target cells and infect other cells.

The invention discloses a reagent combination and a kit for detecting four respiratory tract pathogens based on qPCR, and belongs to the technical field of microbiological detection. Wherein the four respiratory tract pathogens are respectively human adenovirus, human bocavirus, bordetella pertussis and mycoplasma pneumoniae; the kit also comprises an optimized PCR (Polymerase Chain Reaction) buffer solution, DNA (Deoxyribose Nucleic Acid) polymerase and UDG enzyme. Through screening processes such as specific primer probe design, reagent formula and reaction system optimization, high sensitivity and high specificity are maintained while rapid detection is performed, and missing detection and misjudgment are effectively avoided.

The invention belongs to the technical field of pathogen molecular diagnosis, and particularly relates to a mycobacterium tuberculosis detection primer group, method and kit based on multiple PCR (Polymerase Chain Reaction) and high-throughput sequencing. The primer combination aiming at a plurality of high-copy and single-copy gene areas of the mycobacterium tuberculosis is designed through a unique bioinformatics process, and the capturing capacity and amplification efficiency of a low-bacterium-amount sample are fundamentally improved. A pollution discrimination rule based on multi-target consistency verification is established by using NGS multi-target data features, so that pollution identification is internalized into a part of a data analysis process. According to the invention, the optimized mycobacterium tuberculosis specific primer group and the primer pool covering other common respiratory pathogens are integrated in the same multiplex PCR reaction system, so that synchronous and efficient detection of mycobacterium tuberculosis and other pathogens is realized, and the diagnosis efficiency and range are greatly improved.

The application discloses a kind of absolute quantitative detection method of child respiratory tract multi-pathogen based on multi-target ladder microarray and exogenous internal reference correction.The method sets up independent micro-reaction unit to different pathogen, adds fixed amount of exogenous internal reference nucleic acid, and calculates template number by positive unit proportion combined with Poisson distribution model, then corrects the result by using the theoretical addition amount of exogenous internal reference, so as to realize parallel detection and absolute quantification of pathogen such as bocavirus, adenovirus, mycobacterium tuberculosis and mycoplasma pneumoniae without standard curve and special digital PCR equipment.The application has the advantages of high sensitivity, strong anti-interference ability, suitable for mixed infection sample analysis and clinical application, etc.

The invention relates to a household self-test respiratory pathogen nucleic acid detection method and device. The method comprises four steps of sample collection, sample treatment, amplification detection and result interpretation. The device comprises a sample collection device, a sample treatment module, a temperature control module and an amplification detection module. The detection method and device are simple to operate, high in sensitivity, good in specificity, low in cost, free of other electronic components and suitable for rapid detection of household respiratory pathogens, and a result can be rapidly obtained without complex equipment.

The invention belongs to the technical field of pathogen detection, and particularly relates to a freeze-drying PCR reagent, a kit and a method for detecting nucleic acids of six respiratory pathogens. Through optimized and screened freeze-drying stabilizer combination, key components such as primers and probes corresponding to each target and an internal standard, a buffer system and the like are successfully prepared into freeze-dried powder with stable performance under the condition of 2-8 DEG C through a freeze-drying process, and meanwhile, the freeze-dried powder has high sensitivity and high specificity in detection of pathogens, and has a good application prospect. The condition requirements and the cost of the fluorescent PCR reagent in the logistics transportation and storage process are obviously reduced.

This utility model discloses a respiratory suction device, relating to the field of respiratory medicine technology. It includes a device base plate, with an annular fixing assembly fixedly connected to the top of the base plate. A suction container is inserted inside the annular fixing assembly, and a protective cover is inserted into the top of the suction container. A sealing ring is inserted inside the protective cover. Through the sealing ring and the filtration and purification assembly, this utility model achieves safety and filtration effects during operation. The filtration and purification assembly uses multi-layer filtration. The first layer, a polypropylene membrane, with its large pore size, quickly captures larger particulate impurities in the sputum. Two subsequent layers of cellulose filter cotton provide deep purification, intercepting tiny bacteria, viruses, and harmful aerosols. It can filter a large number of respiratory pathogens, greatly reducing the risk of cross-infection in wards. The sealing ring at the bottle opening is made of highly elastic, aging-resistant medical silicone, effectively preventing leakage and improving safety.

The application relates to the technical field of molecular biology detection, in particular to a nucleic acid combination product for identifying respiratory tract pathogens, a PCR premix, a kit and a method. The nucleic acid combination product comprises primer pairs and probes shown in SEQ ID NO: 1 to SEQ ID NO: 21. The primer pairs and the probes can be mixed with other reagents required by PCR, and then freeze-dried to prepare a freeze-dried ball. The freeze-dried ball is smooth and round in surface, and after a nucleic acid sample liquid to be detected is directly dropped into a PCR reaction tube containing the freeze-dried ball, machine detection can be carried out. The freeze-dried ball is not only beneficial to storage and transportation, but also convenient to operate. In particular, the effect of joint detection of target pathogens is good, and the detection sensitivity is also improved.

The invention discloses a respiratory tract pathogen PCR-HRM detection kit and application thereof, and belongs to the technical field of detection, and the kit comprises primer probes as shown in SEQ ID No.1-90. Based on a PCR-HRM (Polymerase Chain Reaction-High Resolution Melting) method, the detection kit for detecting the 26 common pathogens of the respiratory tract syndrome, established by the invention, has the detection sensitivity of 100 Copies / mL (preferably 50 Copies / mL), and can meet the expected requirement of monitoring the pathogens at a port. In the correctness verification process, compared with a tNGS detection result, the conformity of the detected target species is not lower than 96.1%, which indicates that the method has high reliability and accuracy in pathogen detection.

The invention relates to the technical field of molecular biological detection, in particular to a nucleic acid combination product, a PCR premixed solution, a kit and a method for identifying respiratory pathogens. The nucleic acid combination product comprises a primer pair as shown in SEQ ID NO: 1 to SEQ ID NO: 21 and a probe. The primer pair and the probe combination can be mixed with other reagents required by PCR and then freeze-dried to prepare freeze-dried balls, the surfaces of the freeze-dried balls are smooth and round, nucleic acid sample liquid to be detected can be directly dropwise added into a PCR reaction tube filled with the freeze-dried balls and then can be detected on a machine, storage and transportation are facilitated, operation is convenient and fast, the combined detection effect of target pathogens is especially good, and the detection efficiency is high. And the detection sensitivity is also improved.

The invention discloses a detection method for simultaneously determining multiple respiratory pathogens. According to the present invention, with the help of the recognized excellent signal amplification tool-CRISPR / Cas12a system and the DNA nanometer machine, the metal element labeling and the ICP-MS detection technology are assisted, such that the simultaneous detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the influenza A virus (H1N1) and the mycoplasma pneumoniae (MP) in the respiratory pathogens is completed so as to easily maintain the respiratory system safety of the whole human. When a compound formed by Cas12a / crRNA is specifically combined with a corresponding target DNA, the trans-shear activity of a CRISPR / Cas12a system can be activated, so that corresponding DNAzyme can be sheared, a DNA nano machine cannot run, lanthanide series metal elements on the DNA nano machine cannot be released, ICP-MS outputs a low signal, and quantitative analysis of multiple DNAs can be realized. The method for detecting the respiratory pathogens can realize simultaneous detection of multiple components, reduces the detection cost and the sample consumption, and has the advantages of high sensitivity and good specificity.

The application discloses a nucleic acid mass spectrometry technology-based method for identifying common respiratory tract infection pathogens in children. The application provides a complete set of primers, including specific primer group 1 and specific primer group 2; the primer group 1 (i.e. the primer corresponding to well1) is composed of single-stranded DNA molecules shown in sequences 1-17 and single-stranded DNA molecules shown in sequences 24-40; the primer group 2 (i.e. the primer corresponding to well2) is composed of single-stranded DNA molecules shown in sequences 18-23 and single-stranded DNA molecules shown in sequences 41-46. The CCRP-MS of the application is a 23-pathogen determination method combining matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and multiple reverse transcription polymerase chain reaction (MRT-PCR), and can directly detect common respiratory tract pathogens in children.

The invention belongs to the technical field of nucleic acid molecule detection, and particularly relates to an enzyme-free isothermal strand displacement cascade amplification reagent for acute respiratory pathogen detection and application of the enzyme-free isothermal strand displacement cascade amplification reagent. The detection method based on the amplification reagent is based on a nucleic acid reaction system composed of an initiation double strand and two molecular beacons, cyclic amplification is performed through a toehold-mediated strand displacement reaction trigger signal under a constant temperature condition, and end point interpretation is performed through a fluorescence signal. The method does not need enzyme and thermal cycle, is short in detection time, adapts to high-throughput operation of a porous plate, and realizes specific recognition and signal cascade amplification of target nucleic acid under a constant temperature condition, so that rapid, accurate and high-throughput detection of acute respiratory pathogens is realized on the premise of not depending on enzymatic reaction and thermal cycle equipment. In addition, the kit has the advantages of low cost, good stability and wide application range, and is suitable for rapid detection of various acute respiratory pathogens.

This application relates to the field of biotechnology, and particularly to primer pairs, primer-probe compositions, PCR premixes, kits, and methods for detecting multiple respiratory pathogens. Nucleic acid sequences are shown in primer pairs as indicated by SEQ ID NO: 1-2, 4-5, 7-8, 10-11, 13-14, 16-17, 19-20, 22-23, 25-26, 28-29, 31-32, 34-35, 37-38, and 40-41. For target respiratory pathogens, this application designs specific amplification primer pairs, paired with suitable probes, enabling the simultaneous detection of eight targets. Furthermore, the detection process avoids interference from heme, trimethoprim, sulfamethoxazole, amphotericin B, itraconazole, fluconazole, azithromycin, adrenaline, and lidocaine hydrochloride in the test sample. It exhibits good anti-interference properties and shows no cross-reactivity with *Rhodococcus equi*, *Candida tropicalis*, and *Candida krusei*.

The invention discloses a rapid detection kit and device for multiple respiratory pathogens based on a hydrogel micro-fluidic chip, and belongs to the technical field of nucleic acid detection. The device comprises a respiratory tract pathogen detection kit, a portable heating device and an image acquisition and recognition device. The detection strategy that the sample is directly split and is compatible with an amplification system is adopted, a nucleic acid purification step is not needed, and the operation process is remarkably simplified. The multi-partition hydrogel micro-fluidic chip is combined with the RT-LAMP technology, so that rapid detection of various respiratory pathogens is realized, and the pathogens can be accurately quantified to 1 copy / L within 15 minutes. The device integrates a portable heating device and an intelligent image recognition system, is simple and convenient to operate, and can realize household rapid screening and accurate monitoring of respiratory tract pathogens.

The invention belongs to the technical field of molecular detection, and particularly relates to a detection kit for respiratory tract pathogenic bacteria and drug-resistant genes based on a capillary electrophoresis detection platform and application of the detection kit. Compared with a traditional method, the method has the advantages that common respiratory tract infection pathogenic bacteria and drug-resistant genes are covered, detection sites are more comprehensive, specificity is higher, sensitivity is better, reliability is higher, and batch detection capacity is achieved.

The application relates to the technical field of molecular biology detection, in particular to a nucleic acid combination product for identifying respiratory tract pathogens, a PCR premix, a kit and a method. The nucleic acid combination product comprises a primer pair and a probe with sequences shown in SEQ ID NO: 1 to SEQ ID NO: 21. The nucleic acid combination product comprises a primer pair and a probe for detecting target pathogens, and in the process of detecting multiple targets based on the same reaction system, cross-reactions can be avoided, and the interference of drugs can also be avoided. In addition, the nucleic acid combination product is suitable for preparing a freeze-dried reagent, and through the selection of a freeze-drying protective agent component, primer probe damage can be avoided, and the compatibility of multiple components can be improved.

The invention relates to the technical field of molecular diagnosis of respiratory tract infection pathogens, in particular to a molecular marker combination for typing respiratory tract infection pathogens (human metapneumovirus, HMPV) and application of the molecular marker combination in preparation of a kit for typing wild and mutant strains of HMPV. The molecular marker combination is HMPV virus F protein K479R and N482S mutations, and the molecular marker combination is associated with HMPV strain metal ion antagonism. By detecting the marker, the correlation analysis of strain types and functional characteristics can be realized, and the double mutation sites have no obvious function change when acting independently, so that the typing specificity and functional correlation are further ensured. Specifically, the molecular marker combination is associated with the metal ion antagonism of the HMPV strain, and the antagonism of the HMPV to the metal ions is enhanced by double mutation.

The application relates to the field of biological medicine, and discloses application of a GOSR1 gene in prevention and / or treatment of respiratory pathogenic bacteria. By specifically knocking down the GOSR1 gene, the application can reduce the expression level of pathogenic gene and protein, thereby significantly inhibiting the proliferation of the respiratory pathogenic bacteria. In addition, it is disclosed that overexpression of the GOSR1 gene can activate the proliferation of the pathogenic bacteria in cells infected by the respiratory pathogenic bacteria. The application provides a brand-new strategy for treatment of respiratory pathogenic bacteria infection based on the regulation of the GOSR1 gene on the proliferation of the respiratory pathogenic bacteria, and is especially suitable for intervention of influenza A virus infection.

The invention discloses a respiratory tract pathogen prediction method and system based on symptom feature and epidemiological information fusion, and relates to the technical field of medical detection. The method comprises a data acquisition step, a model prediction step, a posterior correction step and a result output step. According to the method, laboratory detection is not needed, pathogens which are most likely to be infected can be rapidly predicted at low cost only by using accessible information such as symptoms, and effective support is provided for rapid screening and detection priority decision-making of primary medical treatment.

Methods and compositions containing a phorbol ester or derivative of a phorbol ester are provided for prevention and treatment of sudden acute respiratory syndrome (SARS) coronavirus infection, including SARS-COV-2 infection and related COVID-19 disease. Also provided are methods and compositions for preventing and treating acute inflammatory conditions and related pathogenic injuries, including Acute Respiratory Distress Syndrome (ARDS) and cytokine storm syndrome (CSS) seen in severe SARS-COV-2 / COVID-19 cases.